Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older
NCT03243877 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2458
Last updated 2018-04-11
Summary
POC Medical Systems has developed a Point of Care system for the screening of breast cancer in the general population. Via a proprietary algorithm, the MammoAlert™ is expected to determine breast cancer's risk level for a subject by identifying the presence in plasma of known biomarkers. The present study aims to determine the Sensitivity and Specificity of the test in plasma samples of subjects of whom the status vis-à-vis breast cancer is known.
Conditions
Interventions
- OTHER
-
MammoAlert Screening Test
Plasma obtained from blood samples will be analyzed with the MammoAlert Screening Test for the presence of known breast cancer bio-markers.
Sponsors & Collaborators
-
POC Medical Systems, Inc.
lead INDUSTRY
Principal Investigators
-
Raghu Ram Pillarisetti, MD · KIMS USHALAKSHMI Centre for Breast Diseases KIMS Hospitals
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-17
- Primary Completion
- 2017-11-26
- Completion
- 2018-08-31
Countries
- India
Study Locations
More Related Trials
-
Prospective Case Collection Study for New Mammography Technologies
NCT05199701 ·Status: RECRUITING ·Phase: NA
-
Automated Breast Ultrasound Screening
NCT02650778 ·Status: COMPLETED
-
A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening
NCT05526872 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT03723928 ·Status: RECRUITING ·Phase: NA
-
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
NCT01879189 ·Status: COMPLETED ·Phase: NA
-
A Trial on the Use of Point-of-care Ultrasound in the Assessment of Breast Symptoms
NCT06932133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
NCT04996316 ·Status: ENROLLING_BY_INVITATION
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678 ·Status: COMPLETED
-
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891 ·Status: COMPLETED ·Phase: NA
-
Digital Mammography Screening Trial (ACRIN6652)
NCT00008346 ·Status: COMPLETED ·Phase: NA
-
CtDNA Based MRD Testing for NAC Monitoring in TNBC
NCT06230185 ·Status: RECRUITING
-
Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI
NCT05800132 ·Status: RECRUITING ·Phase: NA
-
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
NCT02670577 ·Status: COMPLETED
-
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360 ·Status: COMPLETED ·Phase: NA
-
Morbidity After Diagnosis and Treatment of Breast Cancer Patients
NCT00027118 ·Status: COMPLETED
-
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
NCT02888366 ·Status: COMPLETED
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT07076147 ·Status: RECRUITING
-
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
NCT00535327 ·Status: COMPLETED
-
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 ·Status: COMPLETED
-
Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
NCT03511859 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
NCT03255577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MarginProbe® System U.S. Post-Approval Study
NCT02406599 ·Status: UNKNOWN ·Phase: NA
-
Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study
NCT04671498 ·Status: UNKNOWN